EncrypGen

Update your Gene-Chain profile at https://my.encrypgen.com with Covid-19-related data to assist researchers. If you haven't created a profile, upload your DNA test data from most common providers and sell your data for $DNA, and to help scientists now. #blockchain #genomics Dr. David Koepsell #blockchaintechnology #publichealth #precisionmedicine

In stark contrast, IndyGeneUS Bio, through its partnership with The Aurum Institute and its wholly owned subsidiary Global Health innovations (GHI), is leveraging the power of African genomic diversity to address the biases and gaps that plague existing models of precision medicine. This unique positioning not only enables IndyGeneUS Bio to emerge as a disruptor to established players like Retro and Altos Labs but also sets the stage for a transformative movement in biomedicine and clinico-genomic data democratization by 2035. Illumina Illumina Ventures GV (Google Ventures) pH Partners Google Google for Startups ARCH Venture Partners a16z crypto a16z Talent x Opportunity

https://lnkd.in/erDmyEVD

KPMG US supports #IndyGeneUS, a BioFintech Company led by US Army Veteran #blackhistorymonth2025 At KPMG US, “we are helping this up-and-coming innovative and diverse start-up because we feel #IndyGeneUS AI has the potential to drive meaningful industry change.” Dr. Todd Ellis, Global Co-Lead Health Equity “Now is also the time for life sciences, healthcare and other organizations to be intentional about changing research models and doing their part to build research capacity in under resourced communities.” As Mr. Henriques points out “Health equity issues can become a thing of the past with more diverse data repositories and by leveraging next generation genomic sequencing, along with AI and machine learning. These enhanced tools can be trained to sift through millions of genomic data points to identify unique gene targets at the population or sub population level.” “Failing to grasp these opportunities may drastically exacerbate existing health inequalities, creating a world of healthcare haves and have-nots. But getting it right could set healthcare on a much fairer trajectory for the future.” Dr. Todd Ellis Ashraf (Ash) Shehata Charisse Dean Kristin Pothier Joe Zaccaria KPMG KPMG India Teah Iosebashvili Edie Stringfellow Kate Wolin Nicole C. Woitowich John McCalla-Leacy Dali Lakhoua Kabeer Aziz Tobi Oke Michael Petry Mru Patel Patrick Munis Julius Valentine M. Marcus Noel Kathie Ramsey Maria Fares KPMG ESG

Enter IndyGeneUS Bio, a biofintech company in exclusive collaboration with The Aurum Institute and its wholly owned subsidiary GHI. These pioneering organizations are leading a biofintech revolution, one that is detaching Africa’s biotech future from Western control. Their blockchain-powered biobank, with a capacity for 3 million genomic samples, will fuel the development of AI-driven biosimilars—including a direct competitor to Keytruda, the $30 billion-a-year immunotherapy drug.

“Our partnership with The Aurum Institute is more than an agreement; it’s a commitment to fostering a future where Africa is not only a participant but a leader in the genomics and precision medicine field. By leveraging blockchain, we’re setting a new global standard for data security, transparency, and community-focused research.” https://lnkd.in/e6ee5zBn

https://lnkd.in/eqv-gjjA

https://lnkd.in/essP9bvZ

https://lnkd.in/esVFeidX